Atopic Dermatitis Treatment Is Evolving Atopic Dermatitis Treatment Is Evolving

Dupilumab, an anti-IL-4 and anti-IL-13 monoclonal antibody, is indicated in Europe for the treatment of moderate to severe atopic dermatitis that requires systemic treatment.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Dermatology News Source Type: news